Literature DB >> 19379293

Veterinary Co-operative Oncology Group.

David M Vail1.   

Abstract

Year:  2004        PMID： 19379293     DOI： 10.1111/j.1476-5810.2004.0053a.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN： 1476-5810            Impact factor:   2.613


× No keyword cloud information.
  8 in total

1.  Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent.

Authors:  Julia Parrish-Novak; Kelly Byrnes-Blake; Narine Lalayeva; Stefanie Burleson; Janean Fidel; Rhonda Gilmore; Pamela Gayheart-Walsten; Gregory A Bricker; William J Crumb; K S Tarlo; Stacey Hansen; Valorie Wiss; Errol Malta; William S Dernell; James M Olson; Dennis M Miller
Journal:  Int J Toxicol       Date:  2017-03-17       Impact factor: 2.032

2.  Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

Authors:  K S Carlsten; C A London; S Haney; R Burnett; A C Avery; D H Thamm
Journal:  J Vet Intern Med       Date:  2011-12-19       Impact factor: 3.333

3.  Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs.

Authors:  Melissa C Paoloni; Christina Mazcko; Elizabeth Fox; Timothy Fan; Susan Lana; William Kisseberth; David M Vail; Kaylee Nuckolls; Tanasa Osborne; Samuel Yalkowsy; Daniel Gustafson; Yunkai Yu; Liang Cao; Chand Khanna
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

4.  Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer.

Authors:  Jaime F Modiano; Donald Bellgrau; Gary R Cutter; Susan E Lana; Nicole P Ehrhart; Ej Ehrhart; Vicki L Wilke; J Brad Charles; Sibyl Munson; Milcah C Scott; John Pozniak; Cathy S Carlson; Jerome Schaack; Richard C Duke
Journal:  Mol Ther       Date:  2012-07-31       Impact factor: 11.454

5.  A technology platform to assess multiple cancer agents simultaneously within a patient's tumor.

Authors:  S Bahram Bahrami; Beryl A Hatton; Richard A Klinghoffer; Jason P Frazier; Alicia Moreno-Gonzalez; Andrew D Strand; William S Kerwin; Joseph R Casalini; Derek J Thirstrup; Sheng You; Shelli M Morris; Korashon L Watts; Mandana Veiseh; Marc O Grenley; Ilona Tretyak; Joyoti Dey; Michael Carleton; Emily Beirne; Kyle D Pedro; Sally H Ditzler; Emily J Girard; Thomas L Deckwerth; Jessica A Bertout; Karri A Meleo; Ellen H Filvaroff; Rajesh Chopra; Oliver W Press; James M Olson
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

6.  Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma.

Authors:  Melissa Paoloni; Christina Mazcko; Kimberly Selting; Susan Lana; Lisa Barber; Jeffrey Phillips; Katherine Skorupski; David Vail; Heather Wilson; Barbara Biller; Anne Avery; Matti Kiupel; Amy LeBlanc; Anna Bernhardt; Beatrice Brunkhorst; Robert Tighe; Chand Khanna
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

7.  Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.

Authors:  Melissa C Paoloni; Anita Tandle; Christina Mazcko; Engy Hanna; Stefan Kachala; Amy Leblanc; Shelley Newman; David Vail; Carolyn Henry; Douglas Thamm; Karin Sorenmo; Amin Hajitou; Renata Pasqualini; Wadih Arap; Chand Khanna; Steven K Libutti
Journal:  PLoS One       Date:  2009-03-30       Impact factor: 3.240

8.  Outcome and toxicity assessment of feline small cell lymphoma: 56 cases (2000-2010).

Authors:  Kendra V Pope; Alex E Tun; Conor J McNeill; Dorothy C Brown; Erika L Krick
Journal:  Vet Med Sci       Date:  2015-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.